Resistin is a prognostic factor for death in type 2 diabetes

Agnieszka Kapłon‐Cieślicka, Agata Tymińska, Marek Rosiak, Krzysztof Ozierański, Michał Peller, Ceren Eyileten, Agnieszka Kondracka, Justyna Pordzik, Dagmara Mirowska-Guzeł, Grzegorz Opolski,

Diabetes/Metabolism Research and Reviews · 2018 · 24 citations · 23 references

Abstract

Higher resistin is associated with reduced survival in T2D, irrespectively of TNF-α. Resistin concentration of above 11 ng/mL indicates T2D patients at an increased risk of unfavourable outcomes. Leptin was not a prognostic factor. These results suggest that in T2D, association of resistin with unfavourable outcomes might, at least in part, result from its pro-inflammatory properties.

References

23